Related Experiment Video
Updated: Jan 23, 2026

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR
Published on: November 4, 2016
Staphylococcus aureus Orchestrates Type 2 Airway Diseases
Andrea R Teufelberger1, Barbara M Bröker2, Dmitri V Krysko3
1Upper Airways Research Laboratory, Department of Otorhinolaryngology, Ghent University, Ghent, Belgium.
Abstract:
Staphylococcus aureus persistently colonizes the nostrils of one-third of the population but colonizes the sinus mucosa in up to 90% of patients with nasal polyps, implying a possible role in airway disease. Recent findings give new mechanistic insights into the ability of S. aureus to trigger type 2 inflammatory responses in the upper and lower airways. This novel concept of a S. aureus-driven chronic airway inflammatory disease suggests a new understanding of disease triggers. This article reviews the role of S. aureus in chronic inflammatory airway diseases and discusses possible therapeutic approaches to target S. aureus.
Insights
Staphylococcus aureus nasal colonization is common, especially in patients with nasal polyps. New research reveals how this bacterium triggers type 2 inflammation, suggesting it drives chronic airway diseases.
Area of Science:
- Microbiology
- Immunology
- Pulmonology
Background:
- Staphylococcus aureus frequently colonizes the nasal passages in healthy individuals.
- Nasal polyp patients exhibit significantly higher S. aureus colonization rates on sinus mucosa (up to 90%).
- This suggests a potential link between S. aureus and airway pathologies.
Purpose of the Study:
- To review the role of Staphylococcus aureus in chronic inflammatory airway diseases.
- To explore recent mechanistic insights into S. aureus-induced type 2 inflammatory responses.
- To discuss potential therapeutic strategies targeting S. aureus in airway diseases.
Main Methods:
- Literature review of existing studies on S. aureus and airway inflammation.
- Analysis of recent findings on the immunomodulatory effects of S. aureus.
- Synthesis of information on therapeutic targets and approaches.
Main Results:
- S. aureus colonization is highly prevalent in patients with nasal polyps.
- Mechanistic studies demonstrate S. aureus's capacity to elicit type 2 inflammatory responses.
- These responses occur in both upper and lower airways.
Conclusions:
- A novel concept emerges: S. aureus may act as a primary driver of chronic airway inflammatory diseases.
- Understanding S. aureus's role provides new insights into disease pathogenesis.
- Targeting S. aureus presents a promising therapeutic avenue for managing chronic airway inflammation.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
Suctioning the Nasopharyngeal Airway
Equipment Required
Cardiopulmonary Resuscitation II: ACLS Airway Management
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

